Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Ayse Seda, V. Welk (vanessa.welk@googlemail.com / Comprehensive Pneumology Center (CPC), U. Hospital of the Ludwig-Maximilians-University (LMU) and Helmholtz Zentrum München, M. of the German Center for Lung Research (DZL), M. Platz 31, 8. , T. Meul (thomas.meul@helmholtz-muenchen.de / Comprehensive Pneumology Center (CPC), U. Hospital of the Ludwig-Maximilians-University (LMU) and Helmholtz Zentrum München, M. of the German Center for Lung Research (DZL), M. Platz 31, 8. , C. Lukas (tina_lukas@web.de / Comprehensive Pneumology Center (CPC), U. Hospital of the Ludwig-Maximilians-University (LMU) and Helmholtz Zentrum München, M. of the German Center for Lung Research (DZL), M. Platz 31, 8. , I. Koch (ina.koch@asklepios.com / Asklepios Lung Clinic Munich-Gauting, 8. , E. Stacher-Priehse (e.stacher@asklepios.com / Asklepios Lung Clinic Munich-Gauting, 8. , M. Lindner (michael.lindner@helmholtz-muenchen.de / Asklepios Lung Clinic Munich-Gauting, 8. , G. Stathopoulos (georgios.stathopoulos@helmholtz-muenchen.de / Comprehensive Pneumology Center (CPC), U. Hospital of the Ludwig-Maximilians-University (LMU) and Helmholtz Zentrum München, M. of the German Center for Lung Research (DZL), M. Platz 31, 8. , S. Meiners (silke.meiners@helmholtz-muenchen.de / Comprehensive Pneumology Center (CPC), U. Hospital of the Ludwig-Maximilians-University (LMU) and Helmholtz Zentrum München, M. of the German Center for Lung Research (DZL), M. Platz 31, 8.. LSC - 2021 - Regulation of PA200 in lung cancer. 1133

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2021 - Macrophages in lung adenocarcinoma Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 Regulation of PA200 in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 PP138 – Regulation of PA200 in lung cancer Source: ERS Lung Science Conference 2021 Year: 2021 LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017 LSC - 2021 - Preclinical evaluation of IL-1ß inhibition against KRAS-mutant lung adenocarcinoma Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021 LSC - 2017 - Exosomal miRNA cargo in non small-cell lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 LSC - 2018 - A requirement for mast cells in lung adenocarcinoma Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms Year: 2018 LSC - 2021 - Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 LSC - 2017 - Re-education of tumor-associated macrophages by modulating histone deacetylases in lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 LSC - 2021 - cAMP response element-binding protein mediates immune-evasion of KRAS-mutant lung adenocarcinoma Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021 LSC - 2020 - Comprehensive characterization of the immune landscape within different molecular subtypes of small cell lung cancer (SCLC) Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020 Adenylate cyclase-associated protein 1 is associated with metastasis of non-small cell lung cancer especially in brain metastasis patients and promotes the lung cancer cell proliferation and migration in vitro as well as its growth and metastasis in vivo by the signaling pathways of limk1-cofilin Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 Distribution of CD4+Foxp3+,CD4+ and CD8+ T cells in non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Expression of the ILK-PINCH-PARVIN (IPP) complex and its binding partner Rsu-1 in human non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 LSC 2012 abstract – Effects of the Hedgehog (Hh) pathway inhibitor GDC-0449 on lung cancer cells and cisplatin resistant lung cancer cells are mediated by lung cancer stem cells (SPs) Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 CD33+CD14-CD11b+CD66b+CD15+VEGFR-1hi myeloid derived suppressor cells and their clinical relevance in non-small cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013 Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015